Age-associated difference in circulating ACE2, the gateway for SARS-COV-2, in humans: results from the InCHIANTI study

Levels of angiotensin-converting enzyme 2 (ACE2), the gateway for COVID-19 virus into the cells, have been implicated in worse COVID-19 outcomes associated with aging and cardiovascular disease (CVD). Data on age-associated differences in circulating ACE2 levels in humans and the role of CVD and med...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:GeroScience
Autores principales: AlGhatrif, Majd, Tanaka, Toshiko, Moore, Ann Zenobia, Bandinelli, Stefania, Lakatta, Edward G., Ferrucci, Luigi
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813532/
https://ncbi.nlm.nih.gov/pubmed/33462706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-020-00314-w
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares